ABL1 and leukemia: The resulting BCR-ABL1 fusion protein displays constitutive kinase activity, driving unchecked cell growth in several types of leukemia, such as Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) [23].